Pharmafile Logo
Pharmafocus logo
Advanced Search

Charles River restructures as president sets retirement date

July 14, 2009
Research and Development CRO, Charles River

Charles River Laboratories has unveiled a major shake-up its business and sales activities as part of a reorganisation prompted by …

News

Novartis extends TB donation

July 14, 2009
Sales and Marketing Africa, Novartis, TB

Novartis has extended its tuberculosis (TB) drug donation programme to Tanzania. Novartis has already delivered nearly 250,000 TB treatments to …

News

Clinical trials market worth $50bn in 2008

July 14, 2009
Research and Development CRO, strategy

The global clinical trials market topped $50 billion last year and, despite the recent downturn in the fortunes of most …

News

US approval boosts Plavix competitor

July 14, 2009
Research and Development, Sales and Marketing Effient, FDA, US, lilly

US regulator the FDA has approved Lilly and Daiichi Sankyo's Effient, a rival treatment to the world's best-selling blood-thinning drug …

News

Novartis and NHS Alliance collaborate on commissioning guides

July 14, 2009
Sales and Marketing NHS, Novartis, PBC

Novartis has teamed up with the NHS Alliance to launch a series of guides to help practice-based commissioning leaders tackle …

News

World class commissioning: 5 ways pharma can get involved

July 13, 2009
Sales and Marketing NHS, commissioning, healthcare, marketing

The NHS has set its sights unambiguously on achieving World Class Commissioning. After years of being internally-focused, the health service …

Feature

Virgo launches pharma communications blog

July 13, 2009
Medical Communications Virgo, digi

 Specialist healthcare PR agency Virgo Health has launched a blog with the aim of stimulating debate over the future of …

News

Chiesi breaks ground on new R&D headquarters in Palma

July 13, 2009
Research and Development Chiesi, Europe, Italy

Construction of Chiesi's new 70 million euro centre for research and development has begun in Parma, Italy. The Italian company …

News

Contract research sector: news in brief

July 13, 2009
Research and Development Veeda

Pharmafocus presents a round-up of developments in the contract research sector, including Icon's acquisition of biomarker specialist Veeda, layoffs at …

News

AstraZeneca’s AZD3480 progresses in ADHD

July 11, 2009
Sales and Marketing ADHD, Alzheimer's, Alzheimer's ADHD, AstraZeneca

 AstraZeneca is to progress its AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and has agreed to make a $10 million …

News

Adventis Health launches brand competition

July 10, 2009
Medical Communications Adventis

Adventis Health has celebrated its official launch as a fully integrated healthcare communications agency. To mark this milestone, the company …

News

Pfizer to set up new lab in Ireland

July 10, 2009
Manufacturing and Production Europe, Ireland, Pfizer

Pfizer has earmarked an 11 million euro investment for a new kilo-scale R&D facility at its manufacturing facility in Ringaskiddy, …

News

Biopharma company contributes to GSK’s ‘patent pool’

July 10, 2009
Research and Development Orphan

Biopharma company Alnylam Pharmaceuticals is to put some of its intellectual property at the disposal of researchers into neglected tropical …

News

WHO gives Cervarix green light for use in developing nations

July 10, 2009
Research and Development, Sales and Marketing Cervarix, vaccines

News

NICE to reconsider GSK’s Tyverb

July 9, 2009
Research and Development, Sales and Marketing GSK, NICE, Tyverb

NICE is to reconsider Tyverb under its new lenient approach for end-of-life drugs, after GSK appealed its previous rejection of …

News

Victoza launched in UK

July 9, 2009
Sales and Marketing Victoza, diabetes

Novo Nordisk this week launched its much-anticipated type II diabetes treatment Victoza in the UK. Victoza (liraglutide) is the first …

News

New clients for Cegedim Dendrite

July 9, 2009
Medical Communications Cegedim

Cegedim Dendrite, a leading provider of CRM software and healthcare data to the pharma industry, has announced significant growth over …

News

Writing on the wall for ‘pay to delay’ generics deals

July 9, 2009
Research and Development, Sales and Marketing FDA, US, generics

Deals allowing US pharma companies to pay generics competitors to delay the launch of rival products should be ended, according …

News

Genzyme’s woes are a boost for Shire and Protalix

July 9, 2009
Research and Development, Sales and Marketing FDA, Genzyme, US

The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …

News

Europe launches pharma competition crackdown

July 8, 2009
Research and Development Europe, generics

The European Union's competition watchdog has declared a crackdown on pharma industry competition, promising scrutiny of deals which it says …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026